Now I have a good calibration picture. Let me finalize the review.

**Round 1 bracket**: Based on the anchors, the paper sits between 3.5 and 5.5. PEMS (4.75, Reject) is the most directly comparable paper — also proposes cross-disease epidemic transfer learning and was rejected. Papers scoring 5.75+ tended to be accepted with more comprehensive evaluation.

**Round 2**: Narrowing to 4.0–5.0. HG-DCM is slightly below PEMS (4.75) due to the selective reporting issue (mean/median discrepancy not discussed), but above 4.0 due to genuine novelty, practical importance, dataset contribution, and interpretability.

**Final score: 4.5**

Here are all anchors retrieved across both rounds:

| Path | Avg Score | Round | Comparison |
|------|-----------|-------|------------|
| PEMS (DL7JWbdGr3) | 4.75 | 1 & 2 | Most directly comparable — cross-disease epidemic transfer; rejected with similar baseline/evaluation concerns |
| Parameter optimization for epidemiological model (CpiOUOaqh3) | 2.00 | 1 | Much weaker paper; no novel methodology, poor evaluation |
| Tuberculosis prediction (V83xzYnZ5q) | 3.00 | 1 | Weaker paper; no novel methodology, limited evaluation |
| DAM foundation model for forecasting (4NhMhElWqP) | 7.00 | 1 | Stronger paper with extensive evaluation on 18 datasets; accepted |
| Hierarchical Dynamical Systems (Vp2OAxMs2s) | 5.75 | 1 | Stronger paper with comprehensive evaluation; accepted |
| PINNs extrapolation (vQqJJzL2Jf) | 6.00 | 1 | Stronger analysis but also has overclaiming issues; rejected |
| Synthetic Datasets for Spatio-Temporal Graphs (qq0zZMC4SM) | 5.00 | 1 & 2 | Similar contribution (dataset + epidemiological ML); rejected |
| Contrastive Meta Learning for Dynamical Systems (S8nFZ98pmU) | 4.75 | 1 & 2 | Transfer learning for dynamical systems; rejected |
| Generalizing Dynamics Modeling (i1BTP8wFYM) | 5.25 | 1 & 2 | Pre-trained models for dynamical systems; rejected |
| Meta-Learning Nonlinear Dynamical Systems (vfHISoWo2m) | 4.00 | 2 | Similar theme but limited evaluation; rejected |
| Mechanistic Neural Networks (Giwj9cgAIl) | 4.67 | 2 | Mechanistic + neural approach; rejected |
| Saniny Check for Saliency Metrics (Pev2ufTzMv) | 3.75 | 2 | Selective reporting issues; rejected |
| Guide to Misinformation Detection (Jztt1nrjAM) | 3.50 | 2 | Evaluation methodology concerns; rejected |
| Why Sanity Check (ZBL26FX0FT) | 3.00 | 2 | Methodology concerns; rejected |
| DValCards (4mFEb3JvMc) | 4.25 | 2 | Evaluation bias concerns; rejected |

---

## Summary
This paper introduces HG-DCM, a framework for early-stage pandemic forecasting that trains a Residual CNN on historical pandemic data (Ebola, SARS, Dengue, Influenza) and early-stage data from the current outbreak to predict parameters for the DELPHI compartmental model. The core idea—transferring knowledge from past pandemics to stabilize forecasts during the data-scarce "cold-start" phase—is evaluated on early COVID-19 forecasting across 258 locations, claiming improvements over DELPHI, an end-to-end CNN, and a truncated variant (T-DCM).

## Strengths
- **Novel cross-disease transfer learning paradigm with principled motivation**: The paper introduces a genuinely new approach—using historical data from biologically different diseases to guide compartmental model parameter prediction for a novel outbreak. The conceptual argument (Section 1, lines 17–26) that macroscopic spread dynamics share universal patterns across diseases provides a principled justification. The T-DCM ablation in Table 2 shows that removing historical data causes median MAE to degrade (e.g., 1,770.9 for HG-DCM to 2,799.1 for T-DCM at 4 weeks).

- **Significant reduction in DELPHI's overshooting problem**: Figure 4a demonstrates that HG-DCM exhibits markedly fewer overshooting events than standalone DELPHI across all training window lengths. The formal overshooting definition (>5× predicted vs. observed) and the Wilcoxon Signed-rank tests (p < 0.05 for all 12 parameters in Section 3.2.3) provide concrete mechanistic evidence that HG-DCM produces tighter, more conservative parameter estimates.

- **Principled data augmentation with careful information leakage prevention**: The window-shift augmentation uses a retrospectively computed LDoA, and the paper explicitly states "this retrospectively calculated LDoA is never used during inference on the current pandemic, preventing look-ahead bias and information leakage" (Section 2.2). This shows careful experimental design.

- **New multi-pandemic dataset and interpretable parameter analysis**: The constructed dataset (Section 3.1.1) spanning COVID-19, Ebola, SARS, Dengue, and influenza with metadata is a reusable community contribution. The parameter analysis (Figure 5, Wilcoxon tests) provides interpretable evidence for *why* historical guidance works—HG-DCM predicts lower infection rates and death rates consistent with avoiding overfitting to early noise.

## Weaknesses

### Fatal
None.

### Major

- **Selective reporting obscures mean/median MAE contradiction**: Table 2 reveals a stark discrepancy between mean and median MAE. At 4-week training windows, HG-DCM's mean MAE (110,452.4) is ~10× worse than CNN (11,238.1) and ~6× worse than T-DCM (17,691.2), while its median MAE (1,770.9) is the best. This gap indicates extreme catastrophic failures on a subset of locations. Despite this, Section 3.2.2 claims "CNN generally underperforms HG-DCM across all training horizons" (line 188) without qualifying by metric—a claim contradicted by mean MAE at 2 weeks (CNN: 15,600 vs HG-DCM: 18,603) and 4 weeks. The T-DCM comparison (line 190) does qualify with "with respect to median MAE," but the CNN claim does not. For a method marketed as providing "robust" and "stable" forecasts, the existence of catastrophic failures on some locations is directly material to the contribution claim.

- **Conflated ablation design**: T-DCM removes both historical pandemic data AND metadata simultaneously (line 190: "excluded historical pandemic data and meta-data"), making it impossible to determine which component drives the improvement. A factorial ablation (historical data only, metadata only, both, neither) is needed to support the core claim about cross-disease temporal transfer. Without this, the paper cannot distinguish its contribution from simply conditioning on metadata.

- **Ambiguity between cross-disease and cross-location transfer**: The model is trained on "a composite dataset of past pandemics... alongside the available early-stage data (2–8 weeks) from the current pandemic (COVID-19)" (Section 3.1.2). This means the model sees early COVID-19 data from all 258 locations during training, benefiting from both cross-disease historical transfer and cross-location COVID-19 transfer. The paper never clarifies whether the benefit comes primarily from historical pandemics or from spatial sharing within COVID-19 data—a known technique cited in the related work (Panagopoulos et al.).

### Minor

- **Single target pandemic evaluation**: The entire evaluation rests on COVID-19 alone. The premise—that training on Ebola, SARS, Dengue, and Influenza helps forecast a novel outbreak—is not validated across multiple target diseases. A leave-one-pandemic-out evaluation would directly test cross-disease transfer without COVID-19-specific confounds.

- **Selective acknowledgment of EiNNs performance in Table 1**: The paper states HG-DCM "consistently achieves lower MAE in most tasks" (line 138), which is technically correct (6/8 tasks), but doesn't acknowledge that EiNNs outperforms HG-DCM on US 4-week (729,091 vs 2,548,004) and MA 6-week (25,669 vs 39,887).

- **Underspecified sigmoid ranging function**: The sigmoid maps outputs to (0,1), but DELPHI parameters span different physical ranges. The paper does not explain how sigmoid outputs are scaled to actual parameter values, affecting reproducibility.

### Trivial
None.

## Nice-to-Haves
- Report standard deviations or interquartile ranges alongside mean/median MAE in Table 2.
- Analyze which locations produce catastrophic errors for HG-DCM—do they share identifiable characteristics (continent, reporting quality)?
- Compare against spatial transfer learning approaches (Panagopoulos et al.) to isolate cross-disease vs. cross-location transfer value.
- Add leave-one-pandemic-out cross-validation to test generalizable cross-disease transfer.

## Removed Points
These points are flagged to be removed, treat them with caution.
- Harsh critic's claim that EiNNs outperforms HG-DCM on "8-week MA" — verified as incorrect; HG-DCM wins 8-week MA (5,370 vs 10,874). The critic was right about 4-week US and 6-week MA.
- Any criticism about missing appendix content — the appendix is stripped by the parser.

## Novel Insights
The paper's most genuinely novel observation is that macroscopic pandemic dynamics—transmission rate decay patterns, saturation curves—appear transferable across biologically distinct diseases when mediated through a neural network conditioned on metadata. The T-DCM ablation (Table 2) and parameter analysis (Figure 5, Wilcoxon tests) provide converging evidence that historical guidance regularizes parameter estimation toward more conservative, realistic values. However, the mean/median discrepancy suggests this transfer is not uniformly reliable and may fail catastrophically on some locations—a finding the paper does not explore but which is important for the field.

## Suggestions
- Refactor T-DCM ablation into a factorial design: (1) no historical data, no metadata; (2) metadata only; (3) historical data only; (4) both. This is essential to support the cross-disease transfer claim.
- Acknowledge and analyze the mean/median MAE discrepancy. Report which locations produce catastrophic errors and whether they share identifiable characteristics.
- Add leave-one-pandemic-out cross-validation to demonstrate generalizable cross-disease transfer beyond COVID-19.
- Qualify the CNN comparison claim in the text to specify "with respect to median MAE," or explain the mean MAE contradiction.

## Score and Decision

**Calibration anchors** (all 15 retrieved across both rounds listed above):
- Most comparable: PEMS (4.75, Reject) — cross-disease epidemic transfer, similar evaluation concerns
- HG-DCM is slightly below PEMS due to the more serious selective reporting issue, but above the 4.0 range due to genuine novelty, practical importance, interpretability, and dataset contribution

**Bracket**: Round 1: 3.5–5.5. Round 2: 4.0–5.0. **Final: 4.5**

MY FINAL SCORE: <score>4.5</score>
MY FINAL DECISION: <decision>Reject</decision>